It was built to keep us sick and stuck but not anymore. The last 20 seconds of the ad highlights Hims & Hers compounded GLP-1 drugs, calling them affordable, doctor-trusted and formulated in the U.S.A. Additionally, the brand tells viewers that they can access a personalized weight loss treatment plan designed by a doctor to help them achieve their respective goals
Whether CagriSema ultimately occupies a meaningful commercial position in the obesity market will depend substantially on how the FDA evaluates the REDEFINE evidence package and how payers and prescribers weigh a well-evidenced but second-ranked option against the existing approved standard.
Plant Physiol 138: 433440 Khan MS, Haas FH, Samami AA, Gholami AM, Bauer A, Fellenberg K, Reichelt M, Hnsch R, Mendel RR, Meyer AJ, et al
Ahmad F, Zafereo ME
*Correspondence: Edmund Kozie, [email protected]